109 related articles for article (PubMed ID: 19255938)
1. Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat.
Tsuruta K; Kodama T; Serada M; Hori K; Inaba A; Miyake T; Kohira T
Xenobiotica; 2009 Feb; 39(2):125-34. PubMed ID: 19255938
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment.
Hayakawa M; Yamamoto H; Honma T; Mukai N; Higashiyama A; Sugano M; Kubota N; Uegaki S; Sawamura A; Gando S
Shock; 2012 Jun; 37(6):569-73. PubMed ID: 22552020
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.
Ozaki T; Anas C; Maruyama S; Yamamoto T; Yasuda K; Morita Y; Ito Y; Gotoh M; Yuzawa Y; Matsuo S
Nephrol Dial Transplant; 2008 Jan; 23(1):110-9. PubMed ID: 17804460
[TBL] [Abstract][Full Text] [Related]
4. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
5. Renal catabolism of recombinant human soluble CD4 after intravenous administration to male Sprague-Dawley rats.
Hepburn TW; Davis CB; Urbanski JJ; Smith BR; Schaefer WH; Carbonaro MA; Bugelski PJ
Drug Metab Dispos; 1995 Oct; 23(10):1044-50. PubMed ID: 8654191
[TBL] [Abstract][Full Text] [Related]
6. Induction of pulmonary thromboembolism by neutrophil elastase in collagen-induced arthritis mice and effect of recombinant human soluble thrombomodulin.
Matsuoka T; Jin E; Tachihara A; Ghazizadeh M; Nakajima A; Yoshino S; Katayama Y; Kawanami O
Pathobiology; 2008; 75(5):295-305. PubMed ID: 18931532
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of antofloxacin in renally impaired rats.
Pang XY; Liu L; Zhang DM; Wang GJ; Xie L; Liu XD
J Pharm Pharmacol; 2008 May; 60(5):667-70. PubMed ID: 18416945
[TBL] [Abstract][Full Text] [Related]
8. The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats.
Hasegawa N; Kandra TG; Husari AW; Veiss S; Hart WT; Hedgpeth J; Wydro R; Raffin TA
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1831-7. PubMed ID: 8665042
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application.
Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ
Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405
[TBL] [Abstract][Full Text] [Related]
10. Model-based analysis of covariate effects on population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and normal subjects.
Tsuruta K; Yamada Y; Serada M; Tanigawara Y
J Clin Pharmacol; 2011 Sep; 51(9):1276-85. PubMed ID: 21098690
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of radiolabelled quinlukast in rats.
Syrovatko M; Laznickova A; Laznicek M
J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment.
Mouksassi MS; Marier JF; Bax L; Osawa Y; Tsuruta K
Clin Pharmacol Drug Dev; 2015; 4(3):210-7. PubMed ID: 27140801
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the pharmacokinetics of small proteins by iodination.
Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.
Sands H; Li J; Duggaraju R; Kolan HR; Donegan M; Elove GA; Thakur ML
Drug Metab Dispos; 1997 May; 25(5):631-6. PubMed ID: 9152604
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of thrombomodulin alfa in pediatric patients with hematological malignancy and disseminated intravascular coagulation.
Takeuchi M; Tanoshima R; Miyagawa N; Sarashina T; Kato H; Kajiwara R; Ito S; Goto H
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27734584
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the solubility of a poorly soluble hydroxylated metabolite in human urine and its implications for potential renal toxicity.
Merschman SA; Rose MJ; Pearce GE; Woolf EJ; Schaefer BH; Huber AC; Musson DG; Perry KJ; Rush DJ; Varsolona RJ; Matuszewski BK
Pharmazie; 2005 May; 60(5):359-63. PubMed ID: 15918586
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent.
Shin DH; Choi KS; Cho BS; Song S; Moon DC; Hong JT; Lee CK; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1347-53. PubMed ID: 18958427
[TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin in human gestational tissues: placenta, fetal membranes and myometrium.
Uszyński M; Sztenc S; Zekanowska E; Uszyński W
Adv Med Sci; 2006; 51():312-5. PubMed ID: 17357332
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
